025620 — Cha AI Healthkare Co Income Statement
0.000.00%
- KR₩114bn
- KR₩110bn
- KR₩16bn
Annual income statement for Cha AI Healthkare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30,519 | 20,532 | 6,246 | 17,034 | 15,675 |
| Cost of Revenue | |||||
| Gross Profit | 5,936 | 2,526 | 905 | 7,981 | 7,351 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 43,552 | 56,895 | 27,576 | 27,752 | 21,011 |
| Operating Profit | -13,033 | -36,363 | -21,330 | -10,718 | -5,335 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18,557 | -38,704 | -19,511 | -6,787 | -8,283 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22,056 | -38,675 | -19,511 | -6,798 | -9,802 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -21,766 | -38,564 | -21,435 | -6,797 | -9,493 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -21,766 | -38,564 | -21,435 | -6,797 | -9,493 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -9,268 | -8,525 | -3,066 | -1,463 | -2,206 |
| Dividends per Share |